KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $51.0 million.

  • Merck's Gains from Investment Securities rose 10557.99% to $51.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$292.0 million, marking a year-over-year increase of 7211.08%. This contributed to the annual value of -$510.0 million for FY2024, which is 4366.2% down from last year.
  • As of Q3 2025, Merck's Gains from Investment Securities stood at $51.0 million, which was up 10557.99% from -$335.0 million recorded in Q2 2025.
  • Merck's Gains from Investment Securities' 5-year high stood at $386.0 million during Q2 2024, with a 5-year trough of -$914.0 million in Q3 2024.
  • In the last 5 years, Merck's Gains from Investment Securities had a median value of -$171.0 million in 2021 and averaged -$177.1 million.
  • The largest annual percentage gain for Merck's Gains from Investment Securities in the last 5 years was 29108.91% (2024), contrasted with its biggest fall of 116279.07% (2024).
  • Over the past 5 years, Merck's Gains from Investment Securities (Quarter) stood at -$306.0 million in 2021, then skyrocketed by 56.86% to -$132.0 million in 2022, then tumbled by 230.3% to -$436.0 million in 2023, then soared by 123.17% to $101.0 million in 2024, then crashed by 49.5% to $51.0 million in 2025.
  • Its last three reported values are $51.0 million in Q3 2025, -$335.0 million for Q2 2025, and -$109.0 million during Q1 2025.